This may be explained by the fact that G6PD deficiency is associated with multiple changes in metabolic and cellular states (6) with some changes being pro-tumorigenic and other changes being anti-tumorigenic. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.